Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.
about
Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Nonalcoholic fatty liver disease - A multisystem disease?Controversies in the Diagnosis and Management of NAFLD and NASH.Nonalcoholic fatty liver disease and cardiovascular diseaseAssociation of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisAssociations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.Risk factors for fatty liver in the Multicenter AIDS Cohort Study.CORRELATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND FEATURES OF METABOLIC SYNDROME IN MORBIDLY OBESE PATIENTS IN THE PREOPERATIVE ASSESSMENT FOR BARIATRIC SURGERY.Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity.Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male miceSeverity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis.Associations of insulin resistance, inflammation and liver synthetic function with very low-density lipoprotein: The Cardiovascular Health Study.Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study.Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosisRisk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseMetabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study.Amelioration of lipid abnormalities by vitamin therapy in women using oral contraceptivesLipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.Normal weight dyslipidemia: Is it all about the liver?Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States.The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus.Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.Non-HDL cholesterol and LDL cholesterol in the dyslipidemic classification in patients with nonalcoholic fatty liver disease.Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort studyImpaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
P2860
Q26827665-3E32B9BA-F1EB-49CF-934D-B9F704FEF305Q27692035-61455389-43C3-4880-A4FB-0DDC01540E78Q28079077-E2BE5E48-B306-4E1E-9539-80DACF45077EQ30412296-9D84E60D-7B25-4554-A0DF-3C2C7E518FA2Q33886952-B83EBF63-1ED6-49F9-B7BB-51254446C1DAQ33932951-D796067F-C0CE-4E91-B1BE-CD3E9344A8E6Q34011629-D1FE9CE8-A123-4685-BC67-D823D27197F7Q34049896-E322DCFB-160A-40F2-8CFE-349D58ED5FFAQ34680490-36687090-4F12-4453-8CF1-1150A683F111Q34907809-9856A9DF-7EC9-4D88-9F72-F16A77B20F37Q35004571-B5A41644-D16F-487D-9406-160DE8939D46Q35395228-5CDE20D8-0FB7-4CC7-8A7B-F739EE401EE3Q35582273-FC5BD446-D48E-47E5-84BD-32EC78A465F7Q35589319-4FAEDEA6-5B34-4A7D-A2D8-4BB25C58B513Q35716357-C8966E73-9962-4350-A738-D75CE4AE2945Q35850407-7F3651E0-A04E-410E-9FD6-D092DC33A12AQ35903742-EC21FD1B-3B50-47DE-B804-C27373E667C2Q36496717-4D705024-155D-4E8E-A879-4B4BFD4F2F59Q36599680-55459AD4-2805-4A4B-B1D4-3CB7376D8A98Q36905761-8542ADDD-E1DA-4DEF-96A3-F5BBD6DDACF3Q37088653-6E3A6626-19FC-4E36-B97A-1CC2E85A9279Q37411158-5180EBF0-8DE4-4D1D-86D1-AB572613CC4CQ37517243-14C02096-1397-4FD8-93DE-9DDC8CCFA581Q37548563-A0AE9D4F-41AB-498A-8D5B-85D43F8CAEBCQ37596189-357634B3-9131-4C41-8F6C-D49D641FD4F1Q37633361-F91A472A-08C1-45D6-94E4-329E77280809Q37669751-70BCC73F-6E5C-4C44-A78B-82FA59A84938Q37705810-63EE5B6A-A1A4-4327-8963-4706D91E498AQ38580885-96FE5D84-D5E8-4FB4-9EE5-AD5FC3570030Q38730392-C9C72137-D5E1-4DA1-8B2F-021484CE744BQ41706857-1A463BED-6281-4A4D-A681-1FDCEEAB4500Q41722812-4586AAA6-49C2-4A42-8A92-57DCD658B5C1Q45408801-5ADD58C2-7B65-4E83-938A-BA0D46C36E23Q47131162-32FBC06C-EC15-48FE-A78D-CD4B3E4EE1A4Q55266683-05A5AC88-B021-4482-AE12-15B84B3D6E57Q58731134-C7E4D3DE-C231-4AD5-83F4-2E7FB1403BD5Q58802369-35FEA0AF-CF23-450F-8905-8F341D024D20
P2860
Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.
@ast
Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.
@en
type
label
Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.
@ast
Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.
@en
prefLabel
Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.
@ast
Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.
@en
P2093
P2860
P1433
P1476
Nonalcoholic fatty liver disea ...... hnic Study of Atherosclerosis.
@en
P2093
Andrew Paul DeFilippis
Michael J Blaha
Robert M Reed
Roger S Blumenthal
Seth S Martin
Steven R Jones
P2860
P304
P356
10.1016/J.ATHEROSCLEROSIS.2013.01.022
P577
2013-01-29T00:00:00Z